Otonomy to Report First Quarter 2019 Financial Results and Provide Corporate Update SAN DIEGO, April 29, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...

Preliminary results for Phovia™ in the treatment of Canine Chronic Otitis to be presented at ECVS scientific meeting DUBLIN, Ireland, March 27, 2017 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘Klox’) has announced that the European College of Veterinary Surgeons (‘ECVS’)...

Otonomy to Present at the Bank of America Merrill Lynch Healthcare Conference SAN DIEGO, May 05, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...